Opinion

Video

Optimizing Transitions of Care for Hepatic Encephalopathy Patients

Key opinion leaders emphasize crucial factors for pharmacists to consider, such as medication costs, staying updated on the latest hepatic encephalopathy (HE) clinical advancements and trials, and understanding disease incidence, which can help prevent recurrence, reduce healthcare costs, and improve patients' cognitive function when managed effectively.

Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
Neuron cells, brain activity -- Image credit: Matthieu | stock.adobe.com
March 4th 2024

Integration of DBS Shows Promise Identifying Dysfunctional Brain Circuits, Treating Brain Disorders

Gillian McGovern, Assistant Editor
Elderly man putting together a puzzle -- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
February 5th 2024

Study Results Highlight Importance of Overcoming Stigma When Addressing Brain Health

Gillian McGovern, Assistant Editor
3d illustration of human body organ -- Image credit: PIC4U | stock.adobe.com
January 22nd 2024

Study Findings Suggest Liver Creates Palmitic Acid, Maintaining Brain Health

Gillian McGovern, Assistant Editor
Burgundy ribbon for multiple myeloma cancer awareness
January 15th 2024

Individuals With Obesity More Likely to Have MGUS, A Multiple Myeloma Precursor

Gillian McGovern, Assistant Editor
FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer
January 9th 2024

FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer

Gillian McGovern, Assistant Editor
Image credit: Dglimages | stock.adobe.com
January 9th 2024

Study Data Show Telemedicine Endocrinology Care Not as Effective as In-Person Care

Erin Hunter, Associate Editor